Funding for this research was provided by:
Danmarks Frie Forskningsfond (102900011B)
ZonMw (09150171910029)
National Institutes of Health (R01-HL131517, R01-HL136389, R01-HL089598, R01-HL163277, R01-HL160992)
European Union (Large-scale integrative project MAESTRIA, No. 965286)
Universitätsklinikum Essen
Article History
Accepted: 13 July 2023
First Online: 4 August 2023
Declarations
:
: Not applicable.
: Open Access funding enabled and organized by Projekt DEAL. No external funding was used in the preparation of this manuscript. AS is supported by the Independent Research Fund Denmark (102900011B). JH is supported by the Netherlands Organization for Scientific Research (NWO/ZonMW Vidi 09150171910029). DD is supported by the National Institutes of Health (R01-HL131517, R01-HL136389, R01-HL089598, R01-HL163277, and R01-HL160992) and the European Union (large-scale integrative project MAESTRIA, No. 965286).
: Dobromir Dobrev has obtained honoraria for educational lectures from Daiichi Sankyo and Novartis and for consultancy from AbbVie. Arnela Saljic and Jordi Heijman declare that they have no potential conflicts of interest that might be relevant to the contents of this manuscript.
: Not applicable.
: Not applicable.
: Not applicable.
: Data sharing not applicable to this article as no datasets were generated.
: Not applicable.
: All authors have participated in writing and reviewing this manuscript.